We use GEPIA2 (http://gepia2.cancer-pku.cn/#index) to analyze The Cancer Genome Atlas (TCGA) data and find that MIR200CHG is upregulated in breast cancer (Fig. 1b), and there are differences in expression between the molecular subtypes (Fig. 1c). The gene discussed is MIR200CHG; the disease is breast cancer.